Healthtech Startups

GenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.

2 investors

Genknowme provides epigenetic blood tests that measure biological age and stress overload to guide individuals and healthcare professionals toward healthier aging and better stress management. The company's tests assess how lifestyle and environmental factors influence DNA methylation patterns and aging processes.

2 investors

Genobank provides a platform for patients to own, control, and monetize their genomic data through blockchain-linked biosamples and AI-powered bioinformatics workflows. The platform enables patients to share their biological data with researchers and clinical trials while maintaining transparency and earning potential from data licensing.

2 investors

Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases. The company partners with hospitals, health systems, and life sciences organizations to deliver expert genetic services at scale.

2 investors

GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.

2 investors

GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases. The company is pursuing regulatory approval and early access programs in Europe.

2 investors

Gento operates a digital marketplace and mobile app that connects independent clinicians with healthcare providers for home health and facility shifts. It lets professionals such as physical therapists, occupational therapists, nurses, and speech pathologists choose assignments on their own terms, schedule, and location.

2 investors

GenVault operates a GxP-compliant biorepository providing secure, temperature-controlled storage, sample management, and lab relocation services for biological, clinical, and biopharmaceutical materials. It serves pharma, biotech, academia, CROs, CDMOs, and government clients, offering ambient/CRT, cold room, freezer/ULT, and cryogenic storage backed by ISO, CAP, and FDA certifications.

2 investors

GeroCare is a home medical service company providing healthcare access to underserved populations across Africa. It leverages technology to deliver medical care to people in remote and underserved segments.

2 investors

Gestalt provides a vendor-neutral digital pathology platform and professional services that enable pathology laboratories and health systems to modernize workflows, integrate AI tools, and manage diagnostic imaging without vendor lock-in. The company serves enterprise hospitals, academic medical centers, and pathology groups seeking interoperable solutions across scanners, laboratory information systems, and AI applications.

2 investors

Gesund develops an AI platform for clinical decision support and medical data analysis. The company serves healthcare providers and clinical researchers.

2 investors

Well Connected develops Allco, a modular care coordination platform that lets community-based organizations share resources, service information, and patient data with role-based and data-element-level access controls. It serves health and social care providers and community organizations, with an emphasis on privacy and regulatory compliance.

2 investors

Ghoonuts conducts research and development using transcranial electrical stimulation technology. The company appears to focus on neuroscience applications, with involvement in clinical neurophysiology and VR domains.

2 investors

Giftshed builds a single-cell cancer data platform that images billions of cells from whole blood, uses Vision AI and robotics to detect and isolate rare circulating tumor cells, and applies single-cell RNA sequencing and multi-omics to guide precision cancer therapy. The platform is aimed at personalized cancer diagnostics and metastatic biology research.

2 investors

Gisens Biotech develops G-LoC, a portable graphene-based biochip technology that delivers rapid health monitoring and diagnostic test results from home samples in minutes rather than days. The company's initial product, KF4+, is designed for patients with chronic kidney disease to perform comprehensive kidney function testing at home with results integrated into electronic health records.

2 investors

Givers Health provides cohort-based group training and support for caregivers using AI-powered experiential scenarios and evidence-based learning content focused on person-centered care and behavioral health.

2 investors

GlaucoT develops a medical device for the treatment of glaucoma, aiming to provide affordable eye care solutions for glaucoma patients. The company operates in the medical device and ophthalmology technology space.

2 investors

Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms. Founded in 1998 and publicly traded on the NYSE, the company serves ophthalmology patients globally.

2 investors

Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.

2 investors

Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.

2 investors

JustScan develops a dental 3D printer, just Print Pro, that lets dental clinics fabricate items such as temporary teeth, veneers, surgical guides, splints, and night guards in-office as part of a digital dentistry workflow. The system is aimed at dental practices, offering scan-to-seat production in around 30 minutes.

2 investors

GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.

2 investors

Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.

2 investors

German Medical Engineering (GME) develops and manufactures medical laser and light systems for clinical skin treatment and renewal. Based in Germany and operating since 2011, the company sells to aesthetic and dermatology practitioners through a global distributor network spanning over 50 countries.

2 investors